List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Europe Sleep Aids Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Europe Sleep Aids Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Europe Sleep Aids Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Europe Sleep Aids Market 36
Figure 12. Breakdown of Europe Sleep Aids Market by Product Type, 2021-2031, % of Revenue 41
Figure 13. Europe Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 41
Figure 14. Europe Sleep Aids Market by Product Type: Smart Bedding, 2021-2031, $ mn 42
Figure 15. Europe Sleep Aids Market by Product Type: Sleep Lab Services, 2021-2031, $ mn 43
Figure 16. Europe Sleep Aids Market by Product Type: Sleep Apnea Devices, 2021-2031, $ mn 44
Figure 17. Europe Sleep Aids Market by Sleep Apnea Devices: Adaptive Servo-Ventilators (ASVs), 2021-2031, $ mn 46
Figure 18. Europe Sleep Aids Market by Sleep Apnea Devices: Positive Airway Pressure (PAP) Devices, 2021-2031, $ mn 47
Figure 19. Europe Sleep Aids Market by Sleep Apnea Devices: Oral Appliances, 2021-2031, $ mn 48
Figure 20. Europe Sleep Aids Market by Sleep Apnea Devices: Facial Interfaces, 2021-2031, $ mn 49
Figure 21. Europe Sleep Aids Market by Sleep Apnea Devices: Other Sleep Apnea Devices, 2021-2031, $ mn 50
Figure 22. Europe Sleep Aids Market by Product Type: Medication, 2021-2031, $ mn 51
Figure 23. Europe Sleep Aids Market by Medication: Prescription Drugs, 2021-2031, $ mn 52
Figure 24. Europe Sleep Aids Market by Medication: OTC Drugs, 2021-2031, $ mn 53
Figure 25. Europe Sleep Aids Market by Medication: Herbal Drugs, 2021-2031, $ mn 54
Figure 26. Europe Sleep Aids Market by Product Type: Wearable Devices, 2021-2031, $ mn 55
Figure 27. Europe Sleep Aids Market by Product Type: Other Product Types, 2021-2031, $ mn 56
Figure 28. Breakdown of Europe Sleep Aids Market by Indication, 2021-2031, % of Sales Revenue 58
Figure 29. Europe Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 58
Figure 30. Europe Sleep Aids Market by Indication: Insomnia, 2021-2031, $ mn 59
Figure 31. Europe Sleep Aids Market by Indication: Sleep Apnea, 2021-2031, $ mn 60
Figure 32. Europe Sleep Aids Market by Indication: Narcolepsy, 2021-2031, $ mn 61
Figure 33. Europe Sleep Aids Market by Indication: Restless Leg Syndrome, 2021-2031, $ mn 62
Figure 34. Europe Sleep Aids Market by Indication: REM Sleep Behavior Disorder, 2021-2031, $ mn 63
Figure 35. Europe Sleep Aids Market by Indication: Sleepwalking, 2021-2031, $ mn 64
Figure 36. Europe Sleep Aids Market by Indication: Other Indications, 2021-2031, $ mn 65
Figure 37. Breakdown of Europe Sleep Aids Market by Distribution Channel, 2021-2031, % of Sales Revenue 67
Figure 38. Europe Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%) 67
Figure 39. Europe Sleep Aids Market by Distribution Channel: Drug Stores, 2021-2031, $ mn 68
Figure 40. Europe Sleep Aids Market by Distribution Channel: E-Commerce, 2021-2031, $ mn 69
Figure 41. Europe Sleep Aids Market by Distribution Channel: Hospital Pharmacies, 2021-2031, $ mn 70
Figure 42. Europe Sleep Aids Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn 71
Figure 43. Breakdown of European Sleep Aids Market by Country, 2021 and 2031, % of Revenue 73
Figure 44. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 74
Figure 45. Sleep Aids Market in Germany, 2021-2031, $ mn 75
Figure 46. Sleep Aids Market in U.K., 2021-2031, $ mn 77
Figure 47. Sleep Aids Market in France, 2021-2031, $ mn 79
Figure 48. Sleep Aids Market in Spain, 2021-2031, $ mn 81
Figure 49. Sleep Aids Market in Italy, 2021-2031, $ mn 83
Figure 50. Sleep Aids Market in Netherlands, 2021-2031, $ mn 85
Figure 51. Sleep Aids Market in Rest of Europe, 2021-2031, $ mn 87
Figure 52. Growth Stage of Europe Sleep Aids Industry over the Forecast Period 89
Europe Sleep Aids market was valued at $ 22,840.5 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices. Highlighted with 32 tables and 52 figures, this 117-page report “Europe Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country. Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Smart Bedding • Sleep Lab Services • Sleep Apnea Devices o Adaptive Servo-Ventilators (ASVs) o Positive Airway Pressure (PAP) Devices o Oral Appliances o Facial Interfaces o Other Sleep Apnea Devices • Medication o Prescription Drugs o OTC Drugs o Herbal Drugs • Wearable Devices • Other Product Types Based on Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Insomnia • Sleep Apnea • Narcolepsy • Restless Leg Syndrome • REM Sleep Behavior Disorder • Sleepwalking • Other Indications By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Stores • E-Commerce • Hospital Pharmacies • Retail Pharmacies Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Advanced Brain Monitoring Inc. Apex Medical Corp. Apnea Sciences Corporation BMC Medical Co., Ltd. Braebon Medical Corp. Cadwell Industries Inc. Cleveland Medical Devices Inc. Compumedics Limited Drive DeVilbiss Healthcare Inc. Fisher & Paykel Healthcare Corp. Ltd. GlaxoSmithKline plc Itamer Medical Ltd. Koninklijke Philips N. V. Merck & Co., Inc. Natus Medical Inc. Nihon Kohden Corporation Pfizer Inc. ResMed Inc. Sanofi S. A. Sleep Number Corporation SleepMed Inc. SomnoMed Inc. Teva Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More